2010 Taro Pharmaceutical Industries Acquired majority stake in a multinational generic Limited manufacturer with established North America presence and a strong dermatology franchise 2009 Products from Forest Lab's Inwood Division Acquired a manufacturer of controlled substances with an 2008 Chattem Chemicals API facility Incorporated Acquired controlled substance manufacturing assets. 2005 Assets of Able Laboratories 2005 Hungarian Operations and Acquired controlled substance APIs and Alkaloida’s Formulation Plant of ICN dosage form manufacturing plant. 2004 Products from Women's first Healthcare Acquired manufacturer of cephalosporin API holding USA 2004 Phlox Pharma and European approvals Initial stake investment in 1996, 100% takeover in 2002. 2002 MJ Pharma Acquired plant with USFDA and UKMHRA approvals for oral dosage forms Chennai based API manufacturer is merged with Sun 2000 Pradeep Drug Company Pharma. 1999 Milmet Laboratories Helped initiate entry in ophthalmology 1999 Gujarat Lyka Organics Initial stake investment in 1996, 100% takeover in 1999. Acquired Cephalexin and 7ADCA actives manufacturing site 1998 Products from NatcoPharma Helped initiate entry in chest and respiratory therapy areas Helped initiate entry in oncology and gynaecology 1997 TamilnaduDadha Pharmaceuticals Limited
2010 Taro Pharmaceutical Industries Limited Acquired majority stake in a multinational generic manufacturer with established North America presence and a strong dermatology franchise 2009 Products from Forest Lab's Inwood Division 2008 Chattem Chemicals Incorporated Acquired a manufacturer of controlled substances with an API facility 2005 Assets of Able Laboratories Acquired controlled substance manufacturing assets. 2005 Hungarian Operations and Formulation Plant of ICN Acquired Alkaloida’s controlled substance APIs and dosage form manufacturing plant. 2004 Products from Women's first Healthcare 2004 Phlox Pharma Acquired manufacturer of cephalosporin API holding USA and European approvals 2002 MJ Pharma Initial stake investment in 1996, 100% takeover in 2002. Acquired plant with USFDA and UKMHRA approvals for oral dosage forms 2000 Pradeep Drug Company Chennai based API manufacturer is merged with Sun Pharma. 1999 Milmet Laboratories Helped initiate entry in ophthalmology 1999 Gujarat Lyka Organics Initial stake investment in 1996, 100% takeover in 1999. Acquired Cephalexin and 7ADCA actives manufacturing site 1998 Products from NatcoPharma Helped initiate entry in chest and respiratory therapy areas 1997 TamilnaduDadha Pharmaceuticals Limited Helped initiate entry in oncology and gynaecology